Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Policy / Pricing
  • Biotech leaders pitch Pazdur as next FDA chief
  • Policy / Pricing

Biotech leaders pitch Pazdur as next FDA chief

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

pharminent May 14, 2026 (Last updated: May 14, 2026)

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

Post navigation

Previous: Degron adds $40M to series A, supporting immunology plans for molecular glue platform
Next: With new data, Regenxbio to seek FDA approval of Duchenne gene therapy

Related Stories

  • Policy / Pricing

Mid-cap biotechs join Trump’s latest round of drug pricing deals

pharminent September 1, 2026
  • Policy / Pricing

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

pharminent August 27, 2026
  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.